Skip to main content

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial to Evaluate the Safety and Efficacy of Eculizumab in Patients with Relapsing Neuromyelitis Optica

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, MS & Neuroimmunology

Awarded By

Alexion Pharmaceuticals, Inc.

Start Date

September 1, 2015

End Date

October 9, 2017
 

Administered By

Neurology, MS & Neuroimmunology

Awarded By

Alexion Pharmaceuticals, Inc.

Start Date

September 1, 2015

End Date

October 9, 2017